Trial · NCT00135707
Registered outcomes36
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 36
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite of Pregnancy-associated Hypertension and Serious Adverse Outcomes in the Mother or Fetus or Neonate | 20 weeks through discharge following delivery | Severe hypertension (blood pressure \[BP\]\>= 160/110) or mild hypertension (BP\>= 140/90) \>= 20 weeks gestation in conjunction with one of the following: elevated liver enzymes, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, an indicated preterm birth before 32 weeks of gestation owing to hypertension-related disorders, a fetus that was small for gestational age (below 3rd percentile) adjusted for sex and race or ethnic group, fetal death after 20 weeks of gestation, or neonatal death |
| Primary | Severe Hypertension | 20 weeks through discharge following delivery | Included here are women who had severe hypertension only and those who had severe hypertension with elevated liver enzyme levels, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, medically indicated preterm birth, fetal-growth restriction, or fetal death after 20 weeks of gestation, or neonatal death. |
| Primary | Severe or Mild Pregnancy-associated Hypertension With Elevated Liver Enzyme Levels | 20 weeks through discharge following delivery | Elevated liver enzyme levels are specified as an aspartate aminotransferase level of \>= 100 U per liter. Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. |
| Primary | Severe or Mild Pregnancy-associated Hypertension With Thrombocytopenia | 20 weeks through discharge following delivery | Thrombocytopenia defined as a platelet count of \<100,000 per cubic millimeter. Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. |
| Primary | Severe or Mild Pregnancy-associated Hypertension With an Elevated Serum Creatinine Level | 20 weeks through discharge following delivery | Elevated serum creatinine defined as ≥1.5 mg per deciliter or 132.6 μmol per liter. Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. |
| Primary | Severe or Mild Pregnancy-associated Hypertension With an Eclamptic Seizure | 20 weeks through discharge following delivery | Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. |
| Primary | Severe or Mild Pregnancy-associated Hypertension With an Indicated Preterm Birth Before 32 Weeks of Gestation Owing to Hypertension-related Disorders | 20 weeks through discharge following delivery | Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. |
| Primary | Severe or Mild Pregnancy-associated Hypertension With a Fetus That Was Small for Gestational Age (Below the 3rd Percentile) Adjusted for Sex and Race or Ethnic Group | 20 weeks through discharge following delivery | Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. |
| Primary | Severe or Mild Pregnancy-associated Hypertension With a Fetal Death After 20 Weeks of Gestation or Neonatal Death | 20 weeks through discharge or prior to discharge following delivery admission | Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. |
| Secondary | Preeclampsia (Mild, Severe, HELLP Syndrome, Eclampsia) | 20 weeks through discharge following delivery | HELLP denotes hemolytic anemia, elevated liver enzymes, and low platelet count. |
| Secondary | Pregnancy Associated Hypertension | 20 weeks through discharge following delivery | |
| Secondary | Medically Indicated Delivery Because of Hypertension | 20 weeks through discharge following delivery | |
| Secondary | Aspartate Aminotransferase ≥100 U/Liter | 20 weeks through discharge | |
| Secondary | Creatinine ≥1.5 mg/dl (133 μmol/Liter) | 20 weeks through discharge | |
| Secondary | Antepartum Bleeding | During pregnancy | |
| Secondary | Premature Rupture of Membranes | During pregnancy | |
| Secondary | Placental Abruption | During pregnancy | |
| Secondary | Cesarean Delivery | Delivery | |
| Secondary | Maternal Death | Delivery through hospital discharge | |
| Secondary | Postpartum Pulmonary Edema | After delivery through discharge |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00135707/registered